Area of research
Surgery · Hepatology
Research interest
Research interests include Cholangiocarcinoma and Gallbladder Cancer Studies, Liver Disease Diagnosis and Treatment, Gallbladder and Bile Duct Disorders, and Liver Diseases and Immunity.
Liver resection with and without vascular resection versus transplantation for de novo perihilar cholangiocarcinoma.
Genetic ablation of interleukin-17A augments fibrosis in a mouse model of cholestatic liver injury.
Anatomic subsets of cholangiocarcinoma: More different than alike.
Reply: Dropout dynamics in RT+LT vs LR for pCCA-An overlooked variable?
Reply: Re-examining neoadjuvant chemoradiation plus transplantation versus liver resection for de novo perihilar cholangiocarcinoma.
Reply: The treatment options for de novo perihilar cholangiocarcinoma require more details.
Multiomics-driven discovery of predictive biomarkers and strategies to overcome resistance to SFK-YAP inhibition in cholangiocarcinoma
Cell-SELEX identifies a DNA aptamer for highly selective in vivo siRNA delivery in cholangiocarcinoma
Cholangiocarcinoma 2026: status quo, unmet needs and priorities
Transposon-based oncogene integration in Abcb4(Mdr2)-/- mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis
Leveraging Multimodal Foundation Models in Biliary Tract Cancer Research.
First-line atezolizumab/bevacizumab or durvalumab/tremelimumab in advanced hepatocellular carcinoma: a real world, multicenter retrospective study
MAIT Cells in Liver Disease.
The oncogenic potential of YAP requires Y357 phosphorylation in cholangiocytes but not in hepatocytes.
Beyond the Black Box: Explainable AI Transforms Hepatocellular Carcinoma Diagnosis at MRI.
The dynamic landscape of cholestatic liver disease.
Failure-to-rescue as a determinant of overall survival following resection for perihilar cholangiocarcinoma.
Dynamic cholangiocyte responses in a murine model of reversible cholestasis: macrophage remodeling and NF-Y-mediated TGFβ1 expression.
The incidence and predictors of false-negative pancreatobiliary fluorescence in situ hybridization (PB-FISH) in biliary strictures: A prospective study.
Syngeneic murine models with distinct immune microenvironments represent subsets of human intrahepatic cholangiocarcinoma
Efficacy and safety of biologics in primary sclerosing cholangitis with inflammatory bowel disease: A systematic review and meta-analysis
IL-17 signaling in primary sclerosing cholangitis patient-derived organoids.
PTEN deficiency induces an extrahepatic cholangitis-cholangiocarcinoma continuum via aurora kinase A in mice
Transposon-based oncogene integration in Abcb4(Mdr2)-/- mice recapitulates high susceptibility to cholangiocarcinoma in primary sclerosing cholangitis
Utility of methylated DNA markers for the diagnosis of malignant biliary strictures
A small molecule MST1/2 inhibitor accelerates murine liver regeneration with improved survival in models of steatohepatitis.
Epigenetic disease markers in primary sclerosing cholangitis and primary biliary cholangitis-methylomics of cholestatic liver disease.
Incidence and Long-Term Outcomes of Biliary Tract Cancers in Olmsted County, Minnesota from 1976 to 2018.
Diagnostic Accuracy Performance of Fluorescence In Situ Hybridization (FISH) for Biliary Strictures: A Systematic Review and Meta-Analysis.
Dual NOX4/NOX1 inhibition by setanaxib halts cholangiocarcinoma progression by impairing cancer associated fibroblast activation
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Surgery · Hepatology →